Search research articles
Contact Us
Filters
Showing results (21-30 of 105) with videos related to
Page
of 11
Sort By:
Trends in Immunology
|
September 17, 2013
The challenges of stratifying patients for trials in inflammatory bowel disease
Paolo Biancheri, Nick Powell, Giovanni Monteleone, et al.
Frontiers in Immunology
|
February 21, 2022
The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
John P Thomas, Dezso Modos, Simon M Rushbrook, et al.
European Journal of Gastroenterology & Hepatology
|
April 16, 2024
Antidepressant treatment in inflammatory bowel disease: a systematic review and meta-analysis
Frances Weston, Ben Carter, Nick Powell, et al.
Nature Reviews. Gastroenterology & Hepatology
|
March 8, 2018
Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management
Mark A Samaan, Polychronis Pavlidis, Sophie Papa, et al.
Nature Reviews. Gastroenterology & Hepatology
|
May 15, 2015
The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD
Rimma Goldberg, Natalie Prescott, Graham M Lord, et al.
Gut
|
February 28, 2019
Depression in inflammatory bowel disease: risk factor, prodrome or extraintestinal manifestation?
Calum D Moulton, Christine Norton, Nick Powell, et al.
The Lancet. Gastroenterology & Hepatology
|
June 13, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply
James L Alexander, Nicholas A Kennedy, Charlie W Lees, et al.
Postgraduate Medical Journal
|
March 9, 2007
Increased prevalence of gastrointestinal symptoms in patients with allergic disease
Nick Powell, Benedict Huntley, Thomas Beech, et al.
Gastrointestinal Endoscopy
|
April 29, 2008
High-risk features confer an increased risk of significant GI pathology in patients aged less than 50 years with dyspepsia
Nick Powell, Joel Mawdsley, Jonathan Hoare, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 16, 2025
Pathogenic CFTR variants as cancer risk modifiers: Findings from the all of us cohort
Tyler Shugg, Abi Colwell, Nick Powell, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 105) with videos related to
Sort By:
Page
of 11
Trends in Immunology
|
September 17, 2013
The challenges of stratifying patients for trials in inflammatory bowel disease
Paolo Biancheri, Nick Powell, Giovanni Monteleone, et al.
Frontiers in Immunology
|
February 21, 2022
The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
John P Thomas, Dezso Modos, Simon M Rushbrook, et al.
European Journal of Gastroenterology & Hepatology
|
April 16, 2024
Antidepressant treatment in inflammatory bowel disease: a systematic review and meta-analysis
Frances Weston, Ben Carter, Nick Powell, et al.
Nature Reviews. Gastroenterology & Hepatology
|
March 8, 2018
Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management
Mark A Samaan, Polychronis Pavlidis, Sophie Papa, et al.
Nature Reviews. Gastroenterology & Hepatology
|
May 15, 2015
The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD
Rimma Goldberg, Natalie Prescott, Graham M Lord, et al.
Gut
|
February 28, 2019
Depression in inflammatory bowel disease: risk factor, prodrome or extraintestinal manifestation?
Calum D Moulton, Christine Norton, Nick Powell, et al.
The Lancet. Gastroenterology & Hepatology
|
June 13, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply
James L Alexander, Nicholas A Kennedy, Charlie W Lees, et al.
Postgraduate Medical Journal
|
March 9, 2007
Increased prevalence of gastrointestinal symptoms in patients with allergic disease
Nick Powell, Benedict Huntley, Thomas Beech, et al.
Gastrointestinal Endoscopy
|
April 29, 2008
High-risk features confer an increased risk of significant GI pathology in patients aged less than 50 years with dyspepsia
Nick Powell, Joel Mawdsley, Jonathan Hoare, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 16, 2025
Pathogenic CFTR variants as cancer risk modifiers: Findings from the all of us cohort
Tyler Shugg, Abi Colwell, Nick Powell, et al.
Page
of 11